Document Detail


Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure.
MedLine Citation:
PMID:  12103265     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We sought to study the expression of bradykinin type-2 receptors (BK-2Rs) in patients with heart failure (HF). BACKGROUND: Recent work in experimental animals has suggested that bradykinin (BK) exerts cardioprotective effects through specific BK-2Rs. However, nothing is known about the regulation of BK-2R expression in the pathogenesis of human HF. METHODS: Human heart tissue was obtained from excised hearts of patients undergoing cardiac transplantation (n = 13) and from normal hearts (n = 6) unsuitable for donation. The patients had HF due to idiopathic dilated cardiomyopathy (IDC) (n = 7) or coronary heart disease (CHD) (n = 6). Tissue samples from the left ventricles were analyzed by competitive reverse-transcriptase-polymerase chain reaction and Western blotting for the expression of BK-2R messenger ribonucleic acid (mRNA) and protein. RESULTS: In both the IDC and CHD hearts, the level of BK-2R mRNA expression was found to be significantly lower (30% and 38% of control values, respectively) than that in normal hearts. Correspondingly, the BK-2R protein level was significantly reduced in both the IDC and CHD hearts (45% and 62% of control values, respectively) and apparently involved all myocardial cell types. The down-regulation of BK-2R expression in failing hearts did not correlate with decreased cellularity or with the expression pattern of other members of the G-protein-coupled receptor superfamily. However, BK-2R down-regulation in the failing hearts was associated with a decrease in endothelial nitric oxide synthase in both IDC (53% of control value) and CHD (43% of control value) hearts. CONCLUSIONS: These results are the first to suggest that a loss of BK-2Rs is involved in the pathogenesis of human HF.
Authors:
Antti Kuoppala; Naotaka Shiota; Jorma O Kokkonen; Inka Liesmaa; Karam Kostner; Mikko Mäyränpää; Petri T Kovanen; Ken A Lindstedt
Related Documents :
12370095 - Effects of astragaloside iv on myocardial calcium transport and cardiac function in isc...
17027825 - Chronic effect of combined treatment with omapatrilat and adrenomedullin on the progres...
9349385 - Effect of at1 receptor blockade on cardiac collagen remodeling after myocardial infarct...
19207725 - Effects of emulsified isoflurane on haemodynamics and cardiomyocyte apoptosis in rats w...
21286275 - Limitations and potential clinical application on contrast echocardiography.
7435815 - Changes in cardiac output during major vascular surgery.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  40     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-07-09     Completed Date:  2002-07-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  119-25     Citation Subset:  AIM; IM    
Affiliation:
Wihuri Research Institute, Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blotting, Western
Cardiomyopathy, Dilated / metabolism
Coronary Disease / metabolism
Down-Regulation
Female
Heart Failure / etiology,  metabolism*
Humans
Male
Middle Aged
Myocardium / metabolism
Nitric Oxide Synthase / biosynthesis
Nitric Oxide Synthase Type III
RNA, Messenger / genetics
Receptor, Bradykinin B2
Receptors, Bradykinin / genetics,  metabolism*,  physiology
Reverse Transcriptase Polymerase Chain Reaction
Ventricular Function, Left / physiology*
Chemical
Reg. No./Substance:
0/RNA, Messenger; 0/Receptor, Bradykinin B2; 0/Receptors, Bradykinin; EC 1.14.13.39/NOS3 protein, human; EC 1.14.13.39/Nitric Oxide Synthase; EC 1.14.13.39/Nitric Oxide Synthase Type III

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite S...
Next Document:  Sympathetic neural mechanisms in white-coat hypertension.